CENTESSA PHARMACEUTICALS PLC Financing Cash Flow
CENTESSA PHARMACEUTICALS PLC reported Financing Cash Flow of $30.47 million for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-05.
Financial Statements › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2026-05-05
- CENTESSA PHARMACEUTICALS PLC net cash provided by (used in) financing activities for the quarter ending 2026-03-31 was $30.47M, a 887.27% increase year-over-year.
- CENTESSA PHARMACEUTICALS PLC net cash provided by (used in) financing activities for the quarter ending 2025-12-31 was $283.40M, a 9464.63% increase year-over-year.
- CENTESSA PHARMACEUTICALS PLC net cash provided by (used in) financing activities for the quarter ending 2025-09-30 was $3.44M, a 98.60% decline year-over-year.
- CENTESSA PHARMACEUTICALS PLC net cash provided by (used in) financing activities for the quarter ending 2025-06-30 was $1.60M, a 98.48% decline year-over-year.
- CENTESSA PHARMACEUTICALS PLC net cash provided by (used in) financing activities for fiscal 2025 was $291.53M, a 20.08% decline from fiscal 2024.
- CENTESSA PHARMACEUTICALS PLC net cash provided by (used in) financing activities for fiscal 2024 was $364.75M, a 1627.29% increase from fiscal 2023.
- CENTESSA PHARMACEUTICALS PLC net cash provided by (used in) financing activities for fiscal 2023 was $21.12M, a 4520.79% increase from fiscal 2022.
- CENTESSA PHARMACEUTICALS PLC net cash provided by (used in) financing activities for fiscal 2022 was $457.00K.
| Period end | Net Cash Provided by (Used in) Financing Activities 1 month | Net Cash Provided by (Used in) Financing Activities 2 month | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 5 month | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 8 month | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 11 month | Net Cash Provided by (Used in) Financing Activities 12 month |
|---|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | $30.47M 10-Q · filed 2026-05-05 | $313.87M derived: sum of 2 quarters · filed 2026-05-05 | $317.30M derived: sum of 3 quarters · filed 2026-05-05 | $318.91M derived: sum of 4 quarters · filed 2026-05-05 | |||||
| 2025-12-31 | $283.40M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $286.84M derived: sum of 2 quarters · filed 2026-03-31 | $288.44M derived: sum of 3 quarters · filed 2026-03-31 | $291.53M 10-K · filed 2026-03-31 | |||||
| 2025-09-30 | $3.44M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $5.04M derived: sum of 2 quarters · filed 2025-11-05 | $8.13M 10-Q · filed 2025-11-05 | $11.09M derived: sum of 4 quarters · filed 2026-05-05 | |||||
| 2025-06-30 | $1.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | $4.69M 10-Q · filed 2025-08-12 | $7.65M derived: sum of 3 quarters · filed 2026-05-05 | $253.64M derived: sum of 4 quarters · filed 2026-05-05 | |||||
| 2025-03-31 | $3.09M 10-Q · filed 2026-05-05 | $6.05M derived: sum of 2 quarters · filed 2026-05-05 | $252.03M derived: sum of 3 quarters · filed 2026-05-05 | $357.35M derived: sum of 4 quarters · filed 2026-05-05 | |||||
| 2024-12-31 | $2.96M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $248.95M derived: sum of 2 quarters · filed 2026-03-31 | $354.26M derived: sum of 3 quarters · filed 2026-03-31 | $364.75M 10-K · filed 2026-03-31 | |||||
| 2024-09-30 | $245.98M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $351.30M derived: sum of 2 quarters · filed 2025-11-05 | $361.79M 10-Q · filed 2025-11-05 | $368.15M derived: sum of 4 quarters · filed 2025-11-05 | |||||
| 2024-06-30 | $105.31M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | $115.81M 10-Q · filed 2025-08-12 | $122.17M derived: sum of 3 quarters · filed 2025-08-12 | $136.91M derived: sum of 4 quarters · filed 2025-08-12 | |||||
| 2024-03-31 | $10.49M 10-Q · filed 2025-05-14 | $16.85M derived: sum of 2 quarters · filed 2025-05-14 | $31.60M derived: sum of 3 quarters · filed 2025-05-14 | $31.61M derived: sum of 4 quarters · filed 2025-05-14 | |||||
| 2023-12-31 | $6.36M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-24 | $21.11M derived: sum of 2 quarters · filed 2025-03-24 | $21.12M derived: sum of 3 quarters · filed 2025-03-24 | $21.12M 10-K · filed 2025-03-24 | |||||
| 2023-09-30 | $14.74M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $14.76M derived: sum of 2 quarters · filed 2024-11-12 | $14.76M 10-Q · filed 2024-11-12 | $14.85M derived: sum of 4 quarters · filed 2024-11-12 | |||||
| 2023-06-30 | $12.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | $12.00K 10-Q · filed 2024-08-13 | $101.00K derived: sum of 3 quarters · filed 2024-08-13 | $325.00K derived: sum of 4 quarters · filed 2024-08-13 | |||||
| 2023-03-31 | $0.00 10-Q · filed 2024-05-13 | $89.00K derived: sum of 2 quarters · filed 2024-05-13 | $313.00K derived: sum of 3 quarters · filed 2024-05-13 | $383.00K derived: sum of 4 quarters · filed 2024-05-13 | |||||
| 2022-12-31 | $89.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | $313.00K derived: sum of 2 quarters · filed 2024-03-28 | $383.00K derived: sum of 3 quarters · filed 2024-03-28 | $457.00K 10-K · filed 2024-03-28 | |||||
| 2022-09-30 | $224.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $294.00K derived: sum of 2 quarters · filed 2023-11-13 | $368.00K 10-Q · filed 2023-11-13 | ||||||
| 2022-06-30 | $70.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $144.00K 10-Q · filed 2023-08-14 | |||||||
| 2022-03-31 | $74.00K 10-Q · filed 2023-05-12 | ||||||||
| 2021-12-31 | $660.15M 10-K · filed 2023-03-30 | ||||||||
| 2021-09-30 | $585.72M 10-Q · filed 2022-11-10 | ||||||||
| 2021-06-30 | $587.71M 10-Q · filed 2022-08-10 | ||||||||
| 2021-03-31 | $241.89M 10-Q · filed 2022-05-16 | ||||||||
| 2021-01-29 | $0.00 10-K · filed 2023-03-30 | ||||||||
| 2020-12-31 | $1.28M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30 | $1.36M derived: sum of 2 quarters · filed 2022-03-30 | $1.36M 10-K · filed 2022-03-30 | ||||||
| 2020-09-30 | $77.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | $77.00K 10-Q · filed 2021-11-15 | |||||||
| 2020-06-30 | $0.00 10-Q · filed 2021-08-16 | ||||||||
| 2019-12-31 | $9.01M 10-K · filed 2022-03-30 |